Pharmacological characterization of the ET(A) receptor in the vascular smooth muscle comparing its analogous distribution in the rat mesenteric artery and in the arterial mesenteric bed

Simple item page
dc.contributor.authorDonoso, MV
dc.contributor.authorFaundez, H
dc.contributor.authorRosa, G
dc.contributor.authorFournier, A
dc.contributor.authorEdvinsson, L
dc.contributor.authorHuidobroToro, JP
dc.date.accessioned2025-01-21T01:34:14Z
dc.date.available2025-01-21T01:34:14Z
dc.date.issued1996
dc.description.abstractThe potency of ET-1, ET-2, and ET-3 to contract the isolated perfused rat arterial mesenteric bed was 2.73 +/- 0.57, 1.63 +/- 0.32, and 144 +/- 30 nM, respectively. The vasomotor effect of the ETs was slow in onset, persistent but reversible. Sarafotoxin S6b mimicked the ETs with a potency twofold lower than ET-1; sarafotoxin S6c and the C-terminal hexapeptide of ET-1 was inactive. ET(B) agonists such as IRL-1620 and AGETB-89 were inactive as vasoconstrictors within the range of concentrations examined. Minor chemical modifications of ET-1 amino acids residues in position 7 or 21 decreased significantly the peptide potency; ET-I analogues with one or none of the disulfide bonds resulted inactive. The vasomotor effect of ETs was blocked in a competitive, reversible, and selective manner by FR 139317 and BQ-123, the latter being about threefold less potent than the former antagonist. The potency of FR 139317 was 20-fold higher to antagonize ET-3 than ET-1, and threefold higher to block ET-2 than ET-1. In strict analogy to FR 139317, BQ-123 was 12-fold more potent to antagonize ET-3 than ET-1, and fourfold more potent to antagonize ET-2 than ET-1. Upon removal of the endothelial cell layer, the vasomotor potency of ET-1 or the antagonist potency of FR 139317 remained unaltered, suggesting that the vasomotor receptors are localized in the arterial smooth muscles. The ET-l-induced vasomotor responses desensitized, an effect not crossed to noradrenaline (NA); perfusion with 10 mu M indomethacin did not alter the vasomotor potency of ET-1, excluding the participation of eicosanoids in the arteriolar effects of ET-1. In isolated rings of the rat mesenteric artery, set to record isometric contractions of the circular muscular layer, the potency of the ETs and their structural analogues was as follows: ET-2 = ET-1 = sarafotoxin S6b > ET-3 > sarafotoxin S6c. The C-terminal hexapeptide of ET-1 and [Ala(1,3,11,15)]ET-1 were inactive. The ET-1-induced vasoconstriction was antagonized in a concentration-dependent fashion by FR 139317. These results allow to conclude that the ET(A) receptors present in the arterial mesenteric circulation are localized in the vascular smooth muscle of the large-sized arteries as well as the smaller arterioles and precapillary vessels of the rat arterial mesenteric bed. Copyright (C) 1996 Elsevier Science Inc.
dc.fuente.origenWOS
dc.identifier.issn0196-9781
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/97533
dc.identifier.wosidWOS:A1996VW86200010
dc.issue.numero7
dc.language.isoen
dc.pagina.final1153
dc.pagina.inicio1145
dc.revistaPeptides
dc.rightsacceso restringido
dc.subjectArterial mesenteric bed
dc.subjectvascular smooth muscle
dc.subjectendothelins
dc.subjectendothelin receptors
dc.subjectendothelin receptors subtype
dc.subjectET(A) receptor antagonist
dc.subjectFR 139317
dc.subjectBQ-123
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titlePharmacological characterization of the ET(A) receptor in the vascular smooth muscle comparing its analogous distribution in the rat mesenteric artery and in the arterial mesenteric bed
dc.typeartículo
dc.volumen17
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas